Jung, L.A.; Demir, S.; Hotes, A.; Hiyama, E.; Hishiki, T.; Indersie, E.; Branchereau, S.; Cairo, S.; Kappler, R.
Targeting HSP90 with Ganetespib to Induce CDK1 Degradation and Promote Cell Death in Hepatoblastoma. Cancers 2025, 17, 1341.
https://doi.org/10.3390/cancers17081341
AMA Style
Jung LA, Demir S, Hotes A, Hiyama E, Hishiki T, Indersie E, Branchereau S, Cairo S, Kappler R.
Targeting HSP90 with Ganetespib to Induce CDK1 Degradation and Promote Cell Death in Hepatoblastoma. Cancers. 2025; 17(8):1341.
https://doi.org/10.3390/cancers17081341
Chicago/Turabian Style
Jung, Lea Amelie, Salih Demir, Alina Hotes, Eiso Hiyama, Tomoro Hishiki, Emilie Indersie, Sophie Branchereau, Stefano Cairo, and Roland Kappler.
2025. "Targeting HSP90 with Ganetespib to Induce CDK1 Degradation and Promote Cell Death in Hepatoblastoma" Cancers 17, no. 8: 1341.
https://doi.org/10.3390/cancers17081341
APA Style
Jung, L. A., Demir, S., Hotes, A., Hiyama, E., Hishiki, T., Indersie, E., Branchereau, S., Cairo, S., & Kappler, R.
(2025). Targeting HSP90 with Ganetespib to Induce CDK1 Degradation and Promote Cell Death in Hepatoblastoma. Cancers, 17(8), 1341.
https://doi.org/10.3390/cancers17081341